BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 14740972)

  • 1. Conservation therapy in T1-T2 breast cancer: past, current issues, and future challenges and opportunities.
    Perez CA
    Cancer J; 2003; 9(6):442-53. PubMed ID: 14740972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
    Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.
    Freedman G; Fowble B; Hanlon A; Nicolaou N; Fein D; Hoffman J; Sigurdson E; Boraas M; Goldstein L
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1005-15. PubMed ID: 10421533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
    Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
    Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast conservation therapy in patients with stage T1-T2 breast cancer: current challenges and opportunities.
    Perez CA
    Am J Clin Oncol; 2010 Oct; 33(5):500-10. PubMed ID: 20924225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the placement of surgical clips within the excision cavity influence local control for patients treated with breast-conserving surgery and irradiation.
    Fein DA; Fowble BL; Hanlon AL; Hoffman JP; Sigurdson ER; Eisenberg BL
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1009-17. PubMed ID: 8600083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E; Haffty BG
    Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: a nonrandomized comparison.
    Perez CA; Taylor ME; Halverson K; Garcia D; Kuske RR; Lockett MA
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):995-1007. PubMed ID: 8600112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast preservation in stage I and II carcinoma of the breast. The University of Chicago experience.
    Heimann R; Powers C; Halpem HJ; Michel AG; Ewing CA; Wyman B; Recant W; Weichselbaum RR
    Cancer; 1996 Oct; 78(8):1722-30. PubMed ID: 8859185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast conservation treatment of early stage breast cancer: patterns of failure.
    Leborgne F; Leborgne JH; Ortega B; Doldan R; Zubizarreta E
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):765-75. PubMed ID: 7860387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
    Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy.
    Rodrigues N; Carter D; Dillon D; Parisot N; Choi DH; Haffty BG
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1331-5. PubMed ID: 12459354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is a higher boost dose of radiation necessary after breast-conserving therapy for patients with breast cancer with final close or positive margins?
    Sadek BT; Homayounfar G; Abi Raad RF; Niemierko A; Shenouda MN; Keruakous AR; Specht MC; Taghian AG
    Breast Cancer Res Treat; 2015 Nov; 154(1):71-9. PubMed ID: 26420403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of age on the risk of ipsilateral breast tumor recurrence after breast-conserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation.
    Ono Y; Yoshimura M; Hirata K; Yamauchi C; Toi M; Suzuki E; Takada M; Hiraoka M; Mizowaki T
    Radiat Oncol; 2019 Jul; 14(1):121. PubMed ID: 31291997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger.
    Freedman GM; Fowble BL; Hanlon AL; Myint MA; Hoffman JP; Sigurdson ER; Eisenberg BL; Goldstein LJ; Fein DA
    Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):599-605. PubMed ID: 9635708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who should not undergo breast conservation?
    Nijenhuis MV; Rutgers EJ
    Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy.
    Gage I; Schnitt SJ; Nixon AJ; Silver B; Recht A; Troyan SL; Eberlein T; Love SM; Gelman R; Harris JR; Connolly JL
    Cancer; 1996 Nov; 78(9):1921-8. PubMed ID: 8909312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and state-of-the-art indications for boost irradiation in invasive breast carcinoma.
    Polo A; Polgár C; Hannoun-Levi JM; Guinot JL; Gutierrez C; Galalae R; van Limbergen E; Strnad V
    Brachytherapy; 2017; 16(3):552-564. PubMed ID: 28377213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.